Who is sponsoring NCT01399216?

NCT01399216 is sponsored by Hiroshima University.

What drugs are being tested in NCT01399216?

Interventions in NCT01399216: Supplement containing fucoidan, EPA, and DHA, Placebo.

What condition does NCT01399216 study?

NCT01399216 studies Low Basal Body Temperature.

Is NCT01399216 still recruiting?

NCT01399216 is currently completed. Last updated 13 December 2012.

Last reviewed 2012-12-13 · How we verify

NCT01399216

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of a Supplement Containing Fucoidan as a Major Component on Basal Body Temperature: a Placebo Controlled, Cross-over Study

Completed NA Last updated 13 December 2012

What this trial tests

NA trial testing Supplement containing fucoidan, EPA, and DHA in Low Basal Body Temperature in 19 participants. Completed in 1 March 2012.

Timeline

1 July 2011

Primary endpoint
1 March 2012

1 March 2012

Quick facts

Lead sponsor	Hiroshima University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	double
Primary purpose	prevention
Enrollment	19
Start date	1 July 2011
Primary completion	1 March 2012
Estimated completion	1 March 2012
Sites	1 location across Japan

Drugs / interventions tested

Supplement containing fucoidan, EPA, and DHA
Placebo

Conditions studied

Low Basal Body Temperature — all drugs for Low Basal Body Temperature →

Sponsor

Hiroshima University

Who can join

Adults 55 to 70, female only, with Low Basal Body Temperature. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Basal body temperature
Time frame: up to 20 weeks

Sponsor's own description

We aim to determine whether a supplement containing fucoidan isolated from Mekabu (sporophyll of Undaria pinnatifida), EPA, and DHA has effects of elevating basal body temperature in subjects with low basal body temperature.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Hiroshima University trials

Trials by the same sponsor.

NCT07527429 — Procedure Manual-Based Simulation Training to Improve Operating Room Nurses' Core Competencies · NA · not yet recruiting
NCT07299799 — Evidence-Based Nursing to Reduce Adverse Events Regarding Ventilator Associated Pneumonia, Pressure Injuries and Central · NA · not yet recruiting
NCT07384650 — Post-stroke Nurse-led Rehabilitation to Improve Functional Activity and Community Participation in Bangladesh · NA · recruiting
NCT07310680 — Impact of mHealth Education on Hemoglobin Level Among Pregnant Women With Anemia in Rural Bangladesh. · NA · not yet recruiting
NCT06871553 — The Self-management Program on Hemodialysis Patients in Cambodia · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01399216 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hiroshima University
Last refreshed: 13 December 2012

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01399216.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing